% | $
Quotes you view appear here for quick access.

CryoLife Inc. Message Board

  • dlhild Mar 21, 2013 5:39 PM Flag

    cardiac tissue update:

    Three years of cardiac tissue sales (check the numbers yourself though):

    Q1 2010 $6,903,000
    Q2 2010 $6,861,000
    Q3 2010 $7,189,000
    Q4 2010 $7,044,000

    Q1 2011 $6,534,000
    Q2 2011 $6,691,000
    Q3 2011 $6,764,000
    Q4 2011 $6,629,000

    Q1 2012 $7,080,000
    Q2 2012 $7,343,000
    Q3 2012 $8,239,000
    Q4 2012 $7,094,000

    I don’t see cardiac tissue adding much value to share price. My reasoning is simple. The only cost center generating cash flow seems to be the BioGlue cost center. I think that the cardiac tissue cost center operating margin is so low, that after subtracting the related operating expenses the tissue cost center has an operating loss. I don’t expect this to change. CRY has never, to my knowledge/recollection, ever said this cost center is currently profitable. CRY is welcome to bring clarification to this subject should they wish.

    Dirty labs and a possible liability tail to boot? Not likely, but the probability is not zero either. So why take a big liability risk when this cost center is effectively just a gerbil wheel factory?

    Amigo, check the numbers and then draw your own conclusions. You are responsible for doing your own due diligence.

17.05-0.20(-1.16%)10:23 AMEDT